Javascript must be enabled to continue!
Mutation Analysis of the LDL Receptor Gene in Indian Families with Familial Hypercholesterolemia
View through CrossRef
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low-density lipoprotein (LDL) level. The disease is caused by several different mutations in the LDL receptor (LDLR) gene. Several mutations have been reported in this gene in patients from several ethnic groups. Early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infraction by the available therapeutic methods. The techniques available for determining the number of the functional LDLR molecules are difficult to carry out and expensive. Our study presents mutation analysis of the LDLR gene in 24 Indian families with FH. Material & Methods: Peripheral blood samples were obtained form individuals after taking informed consent on the condition that each of these individuals had at least one first-degree relative affected with FH. Genomic DNA was isolated, exon-specific intronic primers were designed and used to amplify DNA samples from individuals.PCR products were directly subjected to automated DNA sequencing to detect the mutations. Along with the affected individuals, ten ethnically matched controls were also analyzed to determine the presence of the same mutations. Patients with Nephrotic Syndrome admitted to hospital were excluded from the study. Results: All the 24 patients had total cholesterol level above 300 mg/dl and LDL cholesterol level above 200mg/dl. Sequence analysis of the LDL receptor (LDLR) gene showed 3 novel mutations which have never been reported elsewhere. In exon 10 we reported g.29372_29373insC, which was found in all the 24 patients and was missence mutation coding for C (cysteine) instead of V (valine). Conclusion: Our study reported 3 novel mutations in 24 Indian families. These novel mutations are predicted to produce change in the amino acid and thus leading to the conformational changes in the structure of LDLR protein. Change in the LDLR protein makes the LDL receptor unable to transport the cholesterol in to the cell and hence cholesterol starts accumulating in the blood stream and leads to FH. Key Words: Familial Hypercholesterolemia; Mutation analysis; LDL Receptor gene
DOI: http://dx.doi.org/10.3126/ajms.v2i2.4573
Asian Journal of Medical Sciences 2 (2011) 82-86
Pharmamedix India Publication Pvt Ltd
Title: Mutation Analysis of the LDL Receptor Gene in Indian Families with Familial Hypercholesterolemia
Description:
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low-density lipoprotein (LDL) level.
The disease is caused by several different mutations in the LDL receptor (LDLR) gene.
Several mutations have been reported in this gene in patients from several ethnic groups.
Early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infraction by the available therapeutic methods.
The techniques available for determining the number of the functional LDLR molecules are difficult to carry out and expensive.
Our study presents mutation analysis of the LDLR gene in 24 Indian families with FH.
Material & Methods: Peripheral blood samples were obtained form individuals after taking informed consent on the condition that each of these individuals had at least one first-degree relative affected with FH.
Genomic DNA was isolated, exon-specific intronic primers were designed and used to amplify DNA samples from individuals.
PCR products were directly subjected to automated DNA sequencing to detect the mutations.
Along with the affected individuals, ten ethnically matched controls were also analyzed to determine the presence of the same mutations.
Patients with Nephrotic Syndrome admitted to hospital were excluded from the study.
Results: All the 24 patients had total cholesterol level above 300 mg/dl and LDL cholesterol level above 200mg/dl.
Sequence analysis of the LDL receptor (LDLR) gene showed 3 novel mutations which have never been reported elsewhere.
In exon 10 we reported g.
29372_29373insC, which was found in all the 24 patients and was missence mutation coding for C (cysteine) instead of V (valine).
Conclusion: Our study reported 3 novel mutations in 24 Indian families.
These novel mutations are predicted to produce change in the amino acid and thus leading to the conformational changes in the structure of LDLR protein.
Change in the LDLR protein makes the LDL receptor unable to transport the cholesterol in to the cell and hence cholesterol starts accumulating in the blood stream and leads to FH.
Key Words: Familial Hypercholesterolemia; Mutation analysis; LDL Receptor gene
DOI: http://dx.
doi.
org/10.
3126/ajms.
v2i2.
4573
Asian Journal of Medical Sciences 2 (2011) 82-86.
Related Results
A-231 A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
A-231 A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
Abstract
Background
Patients at high risk for Atherosclerotic Cardiovascular Disease (ASCVD), who do not achieve adequate loweri...
Developing a Modified Low-Density Lipoprotein (M-LDL-C) Friedewald’s Equation as a Substitute for Direct LDL-C Measure in a Ghanaian Population: A Comparative Study
Developing a Modified Low-Density Lipoprotein (M-LDL-C) Friedewald’s Equation as a Substitute for Direct LDL-C Measure in a Ghanaian Population: A Comparative Study
Despite the availability of several homogenous LDL-C assays, calculated Friedewald’s LDL-C equation remains the widely used formula in clinical practice. Several novel formulas dev...
An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
Abstract
Background
The accurate measurement of Low-density lipoprotein cholesterol (LDL-C) is critical in the decision to utilize the new lipid-low...
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
Abstract
Background
Heterozygous familial hypercholesterolemia (HeFH) is characterized by lifelong elevated LDL-C and inc...
PCSK-9 Inhibitors
PCSK-9 Inhibitors
Hyperlipidemia (elevated levels of LDL-C) is a well-known risk factor of cardiovascular diseases (CVD). Statins are well known and proven drugs for the lipid management of those wh...
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Background—
Homozygous familial hypercholesterolemia is a rare, serious disorder with a substantial reduction in low-density lipoprotein (LDL) receptor function, severe...
e0303 Significance of oxidised low-density lipoprotein in coronary atherosclerotic heart disease
e0303 Significance of oxidised low-density lipoprotein in coronary atherosclerotic heart disease
Objective
In this study, control group are people with normal coronary arteries. This study is to discuss the relationship between LDL, OX-LDL and control group, ...
Familial hypercholesterolaemia
Familial hypercholesterolaemia
Abstract
Familial hypercholesterolaemia (OMIM 143890) is characterized by hypercholesterolaemia from birth, with the subsequent development of cutaneous and tendon x...

